rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Mesoblast Limited - American Depositary Shares

MESO · Nasdaq

Health CareBiotechnologyNot moving yet

MESO stood above a rising 150-day average in 17 of the last 52 weekly readings, and has been out of that trend for the last 34 weeks. It is 17.1% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−9 points in four weeks); Health Care: 28% (−6 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 34
Industry in uptrend
18% -9 in 4 wk
Insider buys, 12 months
$75.1M
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
71 (+5)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 17 of 52 weeks.

23 Apr – 22 Oct
18%29%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$72.4MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months6
Sale orders, 12 months0
Buyers · sellers1 · 0
WhoDidSharesTraded
Gregory GeorgeDirector, 10% ownerbought2,324,072at $1.4810 Apr 2026filed 10 Apr 2026
Gregory GeorgeDirector, 10% ownerbought2,324,072at $1.4810 Apr 2026filed 13 Apr 2026
Gregory GeorgeDirector, 10% ownerbought886,890at $1.439 Apr 2026filed 10 Apr 2026
Gregory GeorgeDirector, 10% ownerbought500,000at $14.399 Apr 2026filed 10 Apr 2026
Gregory GeorgeDirector, 10% ownerbought500,000at $14.399 Apr 2026filed 10 Apr 2026
Gregory GeorgeDirector, 10% ownerbought10,000at $14.409 Apr 2026filed 10 Apr 2026
Gregory GeorgeDirector, 10% ownerbought4,760at $14.409 Apr 2026filed 10 Apr 2026
Gregory GeorgeDirector, 10% ownerbought20,000at $14.309 Apr 2026filed 10 Apr 2026
Gregory GeorgeDirector, 10% ownerbought10,000at $14.309 Apr 2026filed 10 Apr 2026
Gregory GeorgeDirector, 10% ownerbought5,240at $14.259 Apr 2026filed 10 Apr 2026
Gregory GeorgeDirector, 10% ownerbought10,000at $14.259 Apr 2026filed 10 Apr 2026
Gregory GeorgeDirector, 10% ownerbought5,000at $14.309 Apr 2026filed 10 Apr 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders71+5 on the quarter
New · exited11 · 6
Reported value$53.2M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
MORGAN STANLEYadded · filed 13 Aug 2026718,608$9.7M+204,177+39.7%
BlackRock, Inc.added · filed 7 Aug 2026664,280$9.0M+33,425+5.3%
SUSQUEHANNA INTERNATIONAL GROUP, LLPadded · filed 14 Aug 2026457,744$6.2M+71,272+18.4%
GOLDMAN SACHS GROUP INCreduced · filed 14 Aug 2026395,612$5.4M-1,603−0.4%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.new · filed 13 Aug 2026259,700$3.5M+259,700
UBS Group AGadded · filed 13 Aug 2026200,053$2.7M+67,480+50.9%
Arax Advisory Partnersadded · filed 10 Aug 2026168,022$2.3M+143,597+587.9%
BANK OF AMERICA CORPreduced · filed 14 Aug 2026100,000$1.4M-40.0%
Penbrook Management LLCunchanged · filed 23 Jul 202687,075$1.2M00.0%
M&G PLCunchanged · filed 6 Aug 202659,100$827K00.0%
31 Mar 2023 – 30 Jun 2026
244872Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Gregory George Company insiderDirector, 10% owner · last 10 Apr 20266 · 0
James Michael Obrien Company insiderChief Financial Officer · last 23 Dec 20250 · 0

Same industry

MRNA ModernaLeading+118%
ENTX Entera BioLeading+51%
XNCR XencorLeading+44%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2026 · to 30 Jun 20261.3%

Analyst forecasts

No analyst forecasts yet.